Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025

Nobel laureate and Google DeepMind CEO Demis Hassabis said Tuesday (Jan. 21) that he expects to see pharmaceutical drugs designed by artificial intelligence (AI) to be in clinical trials by the end of the year.

During a fireside chat at the World Economic Forum in Davos, Switzerland, Hassabis said these drugs are being developed at Isomorphic Labs, a for-profit venture created by Google parent firm Alphabet in 2021 that was tasked to reinvent the entire drug discovery process based on first principles and led by AI.

“That’s the plan,” Hassabis said. — Read More

#strategy

AI Mistakes Are Very Different from Human Mistakes

Humans make mistakes all the time. All of us do, every day, in tasks both new and routine. Some of our mistakes are minor and some are catastrophic. Mistakes can break trust with our friends, lose the confidence of our bosses, and sometimes be the difference between life and death.

Over the millennia, we have created security systems to deal with the sorts of mistakes humans commonly make. … Humanity is now rapidly integrating a wholly different kind of mistake-maker into society: AI. Technologies like large language models (LLMs) can perform many cognitive tasks traditionally fulfilled by humans, but they make plenty of mistakes. It seems ridiculous when chatbots tell you to eat rocks or add glue to pizza. But it’s not the frequency or severity of AI systems’ mistakes that differentiates them from human mistakes. It’s their weirdness. AI systems do not make mistakes in the same ways that humans do.

Much of the friction—and risk—associated with our use of AI arise from that difference. We need to invent new security systems that adapt to these differences and prevent harm from AI mistakes. — Read More

#trust